Cargando…
Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
SIMPLE SUMMARY: The patient-derived xenograft (PDX) model is the in vivo standard for cancer research as a preclinical platform. Besides its merits, we describe the general rationale of various PDX models and the standard procedures of orthotopic models of gastric adenocarcinoma. We also present cha...
Autores principales: | Jin, Jiankang, Yoshimura, Katsuhiro, Sewastjanow-Silva, Matheus, Song, Shumei, Ajani, Jaffer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486659/ https://www.ncbi.nlm.nih.gov/pubmed/37686627 http://dx.doi.org/10.3390/cancers15174352 |
Ejemplares similares
-
Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
por: Rogers, Jane E., et al.
Publicado: (2022) -
Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
por: Rogers, Jane E., et al.
Publicado: (2023) -
Drug resistance and Cancer stem cells
por: Li, Yuan, et al.
Publicado: (2021) -
The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019) -
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022)